Live Quote · AMEXREEDConsumer Defensive· Beverages - Non-Alcoholic

Reed's, Inc.

$1.33 3.10%(+$0.04)
TickerSpark Score
35/100
Weak
60
Valuation
25
Profitability
10
Growth
52
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REED research report →

52-Week Range3% of range
Low
$1.05
Current
$1.33
High
$12.00
Company Overviewdrinkreeds.com

About the company

Reed's, Inc. (symbol: REED) operates as a manufacturer and distributor of premium, all-natural handcrafted beverages. These artisanal concoctions, part of the craft specialty foods sector, are available across a wide geographical footprint, spanning the United States, Canada, Asia, Europe, Australia, and South America.

CEO
Yumin Dai
IPO
2006
Employees
24
HQ
Norwalk, CT, US

Price Chart

-77.83% · this period
$12.00$6.53$1.05Jul 02Dec 31Jul 02
Valuation
Market Cap
$12.46M
P/E
-0.83
P/S
0.40
P/B
5.84
EV/EBITDA
-0.94
Div Yield
0.00%
Profitability
Gross Margin
13.65%
Op Margin
-62.93%
Net Margin
-65.03%
ROE
-496.48%
ROIC
-154.14%
Growth & Income
Revenue
$34.06M · -10.25%
Net Income
$-15,847,000 · -20.49%
EPS
$-1.91 · -16.46%
Op Income
$-15,148,000
FCF YoY
-175.89%
Performance & Tape
52W High
$12.00
52W Low
$1.05
50D MA
$2.16
200D MA
$3.81
Beta
0.22
Avg Volume
27.57K

Get TickerSpark's AI analysis on REED

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 27, 26Warshall Damian Francisother0
Jan 5, 26COHANE NEALother0
Nov 3, 25Johnson Keith Williamother0
Sep 15, 25Tu Michael Carlother0
Sep 15, 25Reejsinghani Tina Sumanother0
Apr 16, 25Wallace Cyril Arthurother0
Jun 4, 25Era Regenerative Medicine Ltdbuy1,075,269
Apr 14, 25Bakker Rudolf Johannes Mariaother0
Dec 31, 24Era Regenerative Medicine Ltdother0
May 23, 23Era Regenerative Medicine Ltdother232,108
Coverage · REED

Our REED coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on REED yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate REED report →
Internal Compare

Similar companies

Peers in the same neighborhood.